Renaissance Technologies

Renaissance Technologies Portfolio holdings

AUM $75.2B
1-Year Return 41.49%
 

Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.

This Quarter Return
+8.19%
1 Year Return
+41.49%
3 Year Return
+105.58%
5 Year Return
+199.51%
10 Year Return
+593.04%
AUM
$73.1B
AUM Growth
+$2.4B
Cap. Flow
-$2.51B
Cap. Flow %
-3.43%
Top 10 Hldgs %
11.25%
Holding
4,601
New
625
Increased
1,395
Reduced
2,029
Closed
525

Top Buys

1
AAPL icon
Apple
AAPL
+$763M
2
AMZN icon
Amazon
AMZN
+$688M
3
TSM icon
TSMC
TSM
+$562M
4
TSLA icon
Tesla
TSLA
+$419M
5
JNJ icon
Johnson & Johnson
JNJ
+$398M

Sector Composition

1 Healthcare 20.8%
2 Technology 15.52%
3 Consumer Discretionary 11.85%
4 Consumer Staples 10.11%
5 Financials 9.6%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
BON
4026
Bon Natural Life
BON
$7.25M
$12K ﹤0.01%
+44
New +$12K
FRSX
4027
Foresight Autonomous Holdings
FRSX
$8.24M
$12K ﹤0.01%
684
-4,070
-86% -$71.4K
ALLR
4028
Allarity Therapeutics
ALLR
$26.5M
0
-$28K
CRBP icon
4029
Corbus Pharmaceuticals
CRBP
$118M
$11K ﹤0.01%
3,423
-22,928
-87% -$73.7K
NVFY icon
4030
Nova Lifestyle
NVFY
$113M
$11K ﹤0.01%
4,849
-240
-5% -$544
SOPA icon
4031
Society Pass
SOPA
$7.14M
$11K ﹤0.01%
+760
New +$11K
VTGN icon
4032
VistaGen Therapeutics
VTGN
$110M
$11K ﹤0.01%
3,493
-121,919
-97% -$384K
EGLX
4033
DELISTED
Enthusiast Gaming Holdings Inc. Common Stock
EGLX
$11K ﹤0.01%
+19,600
New +$11K
ACGN
4034
DELISTED
Aceragen, Inc. Common Stock
ACGN
$11K ﹤0.01%
1,865
+22
+1% +$130
REED
4035
DELISTED
Reeds, Inc. Common Stock
REED
$11K ﹤0.01%
3,196
+310
+11% +$1.07K
PRFX icon
4036
PainReform
PRFX
$2.74M
$10K ﹤0.01%
102
-2
-2% -$196
THAR icon
4037
Tharimmune
THAR
$16.3M
$10K ﹤0.01%
+70
New +$10K
BLCM
4038
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$10K ﹤0.01%
13,700
VYNT
4039
DELISTED
Vyant Bio, Inc. Common Stock
VYNT
$10K ﹤0.01%
14,320
+10,160
+244% +$7.1K
IMDX
4040
Insight Molecular Diagnostics Inc. Common Stock
IMDX
$85.9M
$9K ﹤0.01%
+1,410
New +$9K
RNAZ icon
4041
TransCode Therapeutics
RNAZ
$8.92M
0
PLXP
4042
DELISTED
PLx Pharma Inc. Common Stock
PLXP
$9K ﹤0.01%
+54,500
New +$9K
ASPU
4043
DELISTED
ASPEN GROUP, INC.
ASPU
$9K ﹤0.01%
27,600
-12,450
-31% -$4.06K
CUEN
4044
DELISTED
Cuentas Inc. Common Stock
CUEN
$9K ﹤0.01%
+4,015
New +$9K
HSTO
4045
DELISTED
Histogen Inc. Common Stock
HSTO
$9K ﹤0.01%
+10,600
New +$9K
VRAX icon
4046
Virax Biolabs
VRAX
$2.52M
$8K ﹤0.01%
+1,140
New +$8K
LKCO
4047
DELISTED
Luokung Technology Corp Ordinary Shares
LKCO
$8K ﹤0.01%
208
+28
+16% +$1.08K
AWH
4048
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
$8K ﹤0.01%
1,700
-174
-9% -$819
VISL
4049
DELISTED
Vislink Technologies, Inc. Common Stock
VISL
$8K ﹤0.01%
+720
New +$8K
EFOI icon
4050
Energy Focus
EFOI
$13.3M
$7K ﹤0.01%
3,171
-10,720
-77% -$23.7K